Clinical Trials

Search Clinical Trials By:

-- Select One --

Showing 1 to 5 of 5
1 - 5
Clinical Trials
A Multicenter, Double-blind, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis
A3921133 Phase 3B/4 Randomized Safety Endpoint Study of 2 Doses of Taofacitinib in Comparison to a Tumor Necrosis Factor (TNF) Inhibitor in Subjects with Rheumatoid Arthritis
GS-US-417-0301: A Randomized, Double-blind, Placebo-and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 weeks in Combination with Methotrexate to Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
GS-US-445-4189- A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects with Active Sjogren’s Syndrome
M12-538 Phase 2 Study, Multicenter, Open-Label Extension (OLE) Study in Rheumatoid Arthiritis Subjects Who Have Completed a Preceding Phase 2 Randomized Controlled Trial (RCT) with ABT-494


News & Announcements

Upcoming Events

Oct 29

NIH SBIR Grant Funding Workshop

From 10:00 AM until 5:00 PM

Nov 5